Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Amazon
AMZN
5
Jefferies Financial
JEF
US Stock MarketDetailed Quotes
TNFA TNF Pharmaceuticals
- 0.1943
- -0.0285-12.79%
Trading Apr 29 15:03 ET
1.97MMarket Cap-0.02P/E (TTM)
0.2199High0.1821Low2.17MVolume0.2100Open0.2228Pre Close446.62KTurnover21.46%Turnover RatioLossP/E (Static)10.13MShares3.310052wk High0.20P/B1.97MFloat Cap0.161552wk Low--Dividend TTM10.11MShs Float6469632.0000Historical High--Div YieldTTM16.97%Amplitude0.1615Historical Low0.2050Avg Price1Lot Size
About TNF Pharmaceuticals Company
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.
Company Profile
SymbolTNFA
Company NameTNF Pharmaceuticals
Listing DateJan 23, 2014
Founded1989
CEODr. Christopher C. Chapman, Jr,M.D.
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address1185 Avenue of the Americas,Suite 249
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-856-848-8698
Websitehttp://tnfpharma.com
Company Executives
- Name
- Position
- Salary
- Ian Rhodes
- Interim Chief Financial Officer and Principal Accounting Officer
- 162.00K
- Dr. Mitchell Glass, M.D.
- Director, President and Chief Medical Officer
- 182.33K
- Joshua Nathaniel Silverman
- Chairman of the Board
- 207.00K
- Christopher Charles Schreiber
- Director
- 244.80K
- Stephen Friscia
- Independent Director
- 38.30K
- Jude Uzonwanne
- Independent Director
- 92.00K
- Bill Joe White
- Independent Director
- 92.00K
- Dr. Craig Eagle, M.D.
- Independent Director
- 92.00K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now